About MDNA Life Sciences
MDNA Life Sciences is a Healthcare company based in Jupiter (United States) founded in 2001, and was acquired by Pearsanta in January 2024. Genomic and molecular diagnostics based on mitochondrial genome are provided. MDNA Life Sciences has raised $1.21 million across 4 funding rounds from investors including Pearsanta. The company has 8 employees. MDNA Life Sciences has completed 1 acquisition, including Mitomics. MDNA Life Sciences offers products and services including Mitomic Tests. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Diversified. Its legal entity is MDNA Life Sciences Inc. Its competitors include Guardant Health, Foundation Medicine and ArcherDX; 3 of its 3 listed competitors have raised funding.
Company details
MDNA Life Sciences was established in 2001 in Jupiter, United States, within the genomics sector. Diagnostics and assays centered on the mitochondrial genome are developed for oncology, targeting skin, breast, prostate, and lung cancers. The Prostate Core Mitomic Test functions as the primary offering, detecting high-risk prostate tumors to avoid additional biopsies. Tests are also created for endometriosis, ovarian cancer, lung cancer, and pancreatic cancer.
- Headquarters Jupiter, United States
- Employees 8
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website mdnalifesciences.com
- Social LinkedIn X Facebook
- Acquired by Pearsanta (Jan 2024)
- Legal Name Mdna Life Sciences Inc.
Products & Services of MDNA Life Sciences
MDNA Life Sciences offers a comprehensive portfolio of products and services, including Mitomic Tests.
Blood tests for detecting diseases like cancer via mitochondrial DNA.
Funding Insights of MDNA Life Sciences
MDNA Life Sciences has successfully raised a total of $1.21M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $470 thousand completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.21M
- Total Rounds 4
- Last Round Seed — $470,000
- First Round $100,000
(Jun 2015)
All 4 funding rounds of MDNA Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2019 | $470,000 | Seed | – | – | – |
| Feb 2018 | $227,500 | Seed | – | – | – |
| May 2017 | $410,050 | Seed | – | – | – |
| Jun 2015 | $100,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in MDNA Life Sciences
MDNA Life Sciences has secured backing from 1 investor. Prominent investors backing the company include Pearsanta.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Offers personalized medical diagnostics and monitoring through data-driven technology. | 2023 | pearsanta.com | Richmond, United States |
Investor details for MDNA Life Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MDNA Life Sciences
MDNA Life Sciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Mitomics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Molecular diagnostics are developed using the mitochondrial genome for oncology. | mitomicsinc.com | Thunder Bay, Canada | 2010 | Nov 2014 | •••• |
Complete acquisition details for MDNA Life Sciences
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of MDNA Life Sciences
5 dated milestones of MDNA Life Sciences across 23 years, from founding to its latest funding, stage changes and deals.
Competitors of MDNA Life Sciences
MDNA Life Sciences has 3 listed competitors in our database, 3 of them funded. They include Guardant Health, Foundation Medicine and ArcherDX.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. | |
| archerdx.com | 2013 | Boulder, United States | $152.6M | 429 | Molecular cancer diagnostic products are developed using patented AMP technology. |
Detailed competitors of MDNA Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MDNA Life Sciences
The website of MDNA Life Sciences (mdnalifesciences.com) receives about 3.6K visits a month.
- Monthly visits3.6K
▲ 27.9% vs previous month
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as MDNA Life Sciences (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mdna Life Sciences
Complete news archive for MDNA Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MDNA Life Sciences
MDNA Life Sciences was founded in 2001 and raised its 1st funding round 14 years after it was founded.
MDNA Life Sciences is headquartered in Jupiter, United States. It is registered at Jupiter, Florida, United States.
MDNA Life Sciences is a funded company, having raised a total of $1.21M across 4 funding rounds to date. The company's 1st funding round was a Seed of $100K, raised on Jun 2015.
MDNA Life Sciences has 8 employees.
MDNA Life Sciences was established in 2001 in Jupiter, United States, within the genomics sector. Diagnostics and assays centered on the mitochondrial genome are developed for oncology, targeting skin, breast, prostate, and lung cancers. The Prostate Core Mitomic Test functions as the primary offering, detecting high-risk prostate tumors to avoid additional biopsies. Tests are also created for endometriosis, ovarian cancer, lung cancer, and pancreatic cancer.
MDNA Life Sciences's top competitors include Guardant Health, Foundation Medicine and ArcherDX.
MDNA Life Sciences offers Mitomic Tests.
MDNA Life Sciences has made 1 acquisition, including Mitomics.
MDNA Life Sciences has 1 investor. Key investors include Pearsanta.
MDNA Life Sciences operates through Mdna Life Sciences Inc..
Yes. MDNA Life Sciences was acquired by Pearsanta in January 2024.